Washington D.C. - According Andrew Kitchenman of NJ Spotlight, "The 21st Century Cures Act attracts bipartisan NJ sponsors Pallone and Lance, draws praise from researchers and industry. One of the goals of the bill is to foster “personalized medicine,” in which treatments are tailored to meet the individual genetic profile of a patient." "The importance of these industries to the state helps explain why two of the bipartisan bill’s leading House advocates are from New Jersey: U.S. Rep. Frank Pallone Jr. (D-6th), one of its four cosponsors, and U.S. Rep. Leonard Lance (R-7th)."
Kitchenman continues ,"Lance sponsored a section of the bill that would ease limits on the amount of money that the Food and Drug Administration can spend to test drugs. That would increase the speed at which the FDA can approve drugs. Finding additional federal funding for medical research has grown in urgency since 2013, when a provision of federal budget law known as “sequestration” went into effect, effectively limiting the amount of money many federal programs, including the National Institutes of Health, can spend."
"The NIH is the central source of federal funding for medical and biological research. The 21st Century Cures Act, which the House Energy & Commerce Committee passed unanimously, provides $10 billion to the NIH over the next five years and is a way around the sequestration limits."
For the full story: http://www.njspotlight.com/stories/15/05/21/federal-research-bill-holds-promise-for-personalized-medicine-in-nj/
"The NIH is the central source of federal funding for medical and biological research. The 21st Century Cures Act, which the House Energy & Commerce Committee passed unanimously, provides $10 billion to the NIH over the next five years and is a way around the sequestration limits."
For the full story: http://www.njspotlight.com/stories/15/05/21/federal-research-bill-holds-promise-for-personalized-medicine-in-nj/
